These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12462986)

  • 1. Effects of betamethasone, sulindac and quinacrine drugs on the inflammatory neoangiogenesis response induced by polyurethane sponge implanted in mouse.
    Illanes J; Dabancens A; Acuña O; Fuenzalida M; Guerrero A; Lopez C; Lemus D
    Biol Res; 2002; 35(3-4):339-45. PubMed ID: 12462986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of steroidal and non steroidal drugs on the neovascularization response induced by tumoral TA3 supernatant on CAM from chick embryo.
    Zúñiga J; Fuenzalida M; Guerrero A; Illanes J; Dabancens A; Díaz E; Lemus D
    Biol Res; 2003; 36(2):233-40. PubMed ID: 14513718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors.
    Richter M; Weiss M; Weinberger I; Fürstenberger G; Marian B
    Carcinogenesis; 2001 Jan; 22(1):17-25. PubMed ID: 11159736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation.
    Brown WA; Skinner SA; Malcontenti-Wilson C; Vogiagis D; O'Brien PE
    Gut; 2001 May; 48(5):660-6. PubMed ID: 11302965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.
    Boolbol SK; Dannenberg AJ; Chadburn A; Martucci C; Guo XJ; Ramonetti JT; Abreu-Goris M; Newmark HL; Lipkin ML; DeCosse JJ; Bertagnolli MM
    Cancer Res; 1996 Jun; 56(11):2556-60. PubMed ID: 8653697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?
    Chau I; Cunningham D
    N Engl J Med; 2002 Apr; 346(14):1085-7. PubMed ID: 11932478
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of beta-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice.
    McEntee MF; Chiu CH; Whelan J
    Carcinogenesis; 1999 Apr; 20(4):635-40. PubMed ID: 10223192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer.
    Fu SL; Wu YL; Zhang YP; Qiao MM; Chen Y
    World J Gastroenterol; 2004 Jul; 10(13):1971-4. PubMed ID: 15222049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines.
    Rahman MA; Dhar DK; Masunaga R; Yamanoi A; Kohno H; Nagasue N
    Cancer Res; 2000 Apr; 60(8):2085-9. PubMed ID: 10786664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX provides missing link in mechanism of aspirin in colon cancer.
    Wunsch H
    Lancet; 1998 Jun; 351(9119):1864. PubMed ID: 9652680
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-angiogenic and apoptotic effects of metabolites of sulindac on chick embryo chorioallantoic membrane.
    Elwich-Flis S; Sołtysiak-Pawluczuk D; Spławiński J
    Hybrid Hybridomics; 2003 Feb; 22(1):55-60. PubMed ID: 12713691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).
    Taketo MM
    J Natl Cancer Inst; 1998 Nov; 90(21):1609-20. PubMed ID: 9811310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat.
    Blume C; Heise G; Mühlfeld A; Bach D; Schrör K; Gerhardz CD; Grabensee B; Heering P
    Kidney Int; 1999 Nov; 56(5):1770-8. PubMed ID: 10571785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs.
    Giuliano F; Warner TD
    Br J Pharmacol; 1999 Apr; 126(8):1824-30. PubMed ID: 10372826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is it safe and efficient to use nonsteroidal anti-inflammatory agent by selective reduction of prostaglandin production?].
    Kankaanranta H; Vapaatalo H
    Duodecim; 1996; 112(5):419-24. PubMed ID: 10592604
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effect of sulindac on DMBA-induced hamster cheek pouch carcinogenesis and its derived cell line.
    Segawa E; Hashitani S; Toyohara Y; Kishimoto H; Noguchi K; Takaoka K; Urade M
    Oncol Rep; 2009 Apr; 21(4):869-74. PubMed ID: 19287981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.